banner
Inquiry

Liposomes

Cat. No. Product Name Inquiry
X26-05-ZQ1880 Artemisia annua oil nanoliposomes
X26-05-ZQ1881 Leuprorelin acetate liposomes
X26-05-ZQ1882 Econazole nitrate liposomes
X26-05-ZQ1883 Salvianolic acid B liposomes
X26-05-ZQ1884 Levofloxacin hydrochloride liposomes
X26-05-ZQ1885 Tegafur/gimeracil/oteracil potassium or oxaliplatin combined with paclitaxel liposomes
X26-05-ZQ1886 5-Fluorouracil liposomes
X26-05-ZQ1887 Sodium alginate-coated insulin liposomes
X26-05-ZQ1888 Ginsenoside Rg1 liposomes
X26-05-ZQ1889 Ofloxacin liposomes
X26-05-ZQ1890 Thrombus-targeted urokinase liposomes
X26-05-ZQ1891 Potassium dehydroandrograpolide succinate liposomes
X26-05-ZQ1892 Growth hormone liposomes
X26-05-ZQ1893 Fluorouracil liposomes
X26-05-ZQ1894 RGD analog-modified doxorubicin stealth liposomes
X26-05-ZQ1895 Sparfloxacin liposomes
X26-05-ZQ1896 Ricin-encapsulated galactosylceramide liposomes (ricinGCLs)
X26-05-ZQ1897 N-Trimethyl chitosan hydrochloride (TMC)-coated insulin liposomes
X26-05-ZQ1898 Photosensitive reactive oxygen species-responsive liposomes
X26-05-ZQ1899 PEGylated liposome nanoparticles
X26-05-ZQ1900 Folate-modified oxaliplatin nanoliposomes
X26-05-ZQ1901 PreS1 peptide (2-21 Aa)-mediated liver-targeted liposomes
X26-05-ZQ1902 Wogonin liposomes
X26-05-ZQ1903 Lentinan liposomes
X26-05-ZQ1904 Glycyrrhizin liposomes
X26-05-ZQ1905 Clarithromycin liposomes
X26-05-ZQ1906 Novel dihydroquinoline derivative-targeted liposomes
X26-05-ZQ1907 Triterpene saponin Nobiliside-A liposomes from Holothuria nobilis
X26-05-ZQ1908 Staphylococcal enterotoxin A liposomes
X26-05-ZQ1909 Long-circulating liposomes with active carboxyl termini
X26-05-ZQ1910 Amphiphilic polymer conjugated linoleic acid-modified polylysine polymer liposomes
X26-05-ZQ1911 Teriparatide nasal delivery liposomes
X26-05-ZQ1912 Chitosan-modified DOPC liposomes
X26-05-ZQ1913 Natural soy phosphatidylcholine thermosensitive liposomes
X26-05-ZQ1914 Pore-forming peptide-modified doxorubicin liposomes
X26-05-ZQ1915 Total glucosides of paeony liposomes
X26-05-ZQ1916 Acyclovir liposomes
X26-05-ZQ1917 Soybean-derived sterylglucoside (SG)-modified cationic liposomes
X26-05-ZQ1918 Albendazole liposomes (L-ABZ)
X26-05-ZQ1919 Closantel liposomes

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.